NRTX-1001
Neurona Therapeutics
[]
new preliminary data from the ongoing, first-in-human phase clinical trial of cell therapy nrtx-1011 in individuals with drug-resistant mesial temporal lobe epilepsy suggest thus far that the treatment is safe. #aanam read: 
Delivering healthcare professionals treating neurological diseases quality and relevant information to help achieve the best patient care possible. #MindMoments